相关实验视频

Updated: Jul 10, 2025

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation

Published on: May 30, 2020

调查叉头盒O转录因子1基因与免疫球蛋白E的关系在家尘中虫过敏性喘患者

Rania A Mohamed^1,2, Ahmed ElSadek Fakhr^3,4, Shereen A Baioumy³

¹Department of Biology, Deanship of Educational Services, Qassim University, P.O. Box 5888, Unaizah 56219, Qassim, Saudi Arabia.

Advances in respiratory medicine

|November 21, 2023

概括

总IgE,FoxO1和Sirtuin 1 (SIRT1) 基因表达被分析在家庭灰尘虫 (HDM) 过敏喘患者中. 它们的相互作用表明它们可能是免疫治疗有效性的生物标志物.

科学领域:

免疫学免疫学免疫学
过敏研究研究过敏
生物标志物发现发现

背景情况:

家庭灰尘虫 (HDM) -过敏性喘涉及对常见的空气过敏原的异常免疫反应.
了解免疫生物标志物对于开发免疫治疗的辅助疗法至关重要.
调查特定的生物标志物可以揭示有关疾病机制和治疗疗效的见解.

研究的目的:

为了研究HDM过敏喘患者的全血清IgE,FoxO1和Sirtuin 1 (SIRT1) 基因表达.
在接受或不接受免疫治疗的患者中分析这些生物标志物的相互作用.
探索这些生物标志物在管理HDM过敏喘方面的潜力.

主要方法:

招募120名参与者分为三个组:健康志愿者 (HV),没有免疫治疗的HDM过敏喘 (HDM/AA) 和接受免疫治疗的HDM过敏喘 (HDM/SCIT).
测量总血清IgE水平的测量.
通过RT-qPCR对FoxO1和SIRT1基因表达的量化.

主要成果:

总IgE在HDM/AA组显著升高,在HDM/SCIT组略有下降.
在HDM/SCIT组中,FoxO1和SIRT1基因表达最高.
在HDM/AA组中观察到总IgE和FoxO1/SIRT1之间的负相关性,与HDM/SCIT组中IgE和SIRT1之间的正相关性形成鲜明对比.

结论:

这项研究突出显示了HDM过敏喘患者免疫治疗后总IgE,FoxO1和SIRT1的动态相互作用.
这些生物标志物在监测治疗反应和疾病缓解方面具有潜在的实用性.
需要进一步的广泛研究来验证它们作为预测和预后免疫生物标志物的作用.

关键词:

在FoxO1中,FoxO1是FoxO1的第一个代号.HDM HDM是指高清的高清视频.一个SIRT1系统.过敏性喘过敏性喘基因表达的基因表达方式总体IgE的总量

更多相关视频

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Published on: April 21, 2019

Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System

Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System

Published on: September 20, 2019

相关概念视频

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Asthma-I: Introduction

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

Allergic Reactions

Allergic Reactions